Скачать или смотреть Regulatory and Administrative Components of an IND Application (5/14) REdI 2017

Maureen Dillon-Parker provides an overview of the contents and format of the Investigational New Drug Application (IND), including a discussion of the regulatory and administrative components as well as the preclinical, product quality and clinical components.
-------------------------

FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.

Upcoming training and free continuing education credits: https://www.fda.gov/cdersbia

CDER SBIA 2017 Playlist:    • 2017 CDER Small Business and Industry Assi...  
LinkedIn:   / cder-small-business-and-industry-assistance  
Training resources: https://www.fda.gov/cderbsbialearn

Twitter:   / fda_drug_info  

CDER small business e-mail update subscription: https://updates.fda.gov/subscriptionm...

Email: [email protected]
Phone: (301) 796-6707 I (866) 405-5367